RIVASTIGMINE 3 MG CAPSULE

Rivastigmine Tartrate
$0.1578per EA

Strength

3 mg/1

NDC

72241001203

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203844

On Market Since

10/5/2021

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-5.9%

3M

-10.7%

6M

-13.0%

1Y

-19.8%

3Y

-35.7%

5Y

N/A

All

-28.7%